These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11210639)

  • 1. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections].
    Korviakova EP
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology of acute enteric infection in children with arid zone and effect of probiotics].
    Utemuradova GE
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):98-100. PubMed ID: 19623719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment efficacy in acute intestinal infections, chronic diseases of the gastrointestinal tract and viral hepatitis B using large doses of Russian Bifidumbacterin-forte].
    Gracheva NM; Shcherbakov IT; Avakov AA; Matsulevich TV
    Voen Med Zh; 1999 May; 320(5):51-7, 96. PubMed ID: 10401251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The regulation of microecological disorders of the intestines in newborn infants with perinatal pathology using the new probiotic bifidumbacterin-forte].
    Iakushenko MN; Tkhagapsoeva ZhM; Bondarenko VM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):18-22. PubMed ID: 9460858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM
    Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute intestinal infections and hypertension].
    Brodov LE; Maleev VV; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):108-10. PubMed ID: 8525717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The development and clinical evaluation of the probiotic Bifidumbacterin forte].
    Grigor'ev AV; Bondarenko VM; Abramov NA; Murashova AO; Feklisova LV; Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):92-6. PubMed ID: 9304342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An attempt to use ofloxacin in the treatment of acute intestinal infections].
    Lobzin IuV
    Antibiot Khimioter; 1996; 41(9):96-8. PubMed ID: 9005799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of the eradication of the focus of infection and the synchronized correction of disturbed intestinal microflora in shigellosis patients].
    Shakhmardanov MZ; Bondarenko VM; Isaeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):71-3. PubMed ID: 9949508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
    Chernysheva NA; Mel'nikova KI; Finkel' MP; Izotova ZB
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):37-9. PubMed ID: 8017124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Probiotic strains of enterococci as a means of therapy and prophylaxis of intestinal diseases in children (review of literature)].
    Gonchar NV; Alekhina LA; Suvorov AN
    Eksp Klin Gastroenterol; 2013; (1):74-8. PubMed ID: 23951904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestations and treatment of intestinal dysbacteriosis in patients with Flexner's dysentery].
    Shakhmardanov MZ; Luchshev VI; Bondarenko VM; Isaeva NN
    Klin Med (Mosk); 1997; 75(7):47-9. PubMed ID: 9411056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of intestinal dysbacteriosis].
    Chekman IS
    Lik Sprava; 2000; (7-8):6-11. PubMed ID: 16786636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in the use of bifidumbacterin in children with prolonged intestinal diseases].
    Zatsepin IuK; D'iakova EI; Goncharova GI; Liannaia AM; Kozlova EP; Aleksandrova AM; Kozhevitskaia OB
    Pediatriia; 1970 May; 49(5):62-4. PubMed ID: 5447911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.